|
The Council for Responsible Nutrition
The Council for Responsible Nutrition (CRN), one of the dietary supplement industry's leading trade associations, recently appointed Pharmanex to its board of directors and welcomed Pharmanex as a new member company of the organization. As a member of the board, Pharmanex will help steer the direction of one of the dietary supplement industry's most powerful organizations.
Peking University Health Science Center
Pharmanex has built a clinical research center on the campus available to students and faculty.
Institute of Materia Medica, Beijing
Research institute that has conducted numerous studies on CordyMax® Cs-4®. This institute developed the original Cs-4® strain.
Peking University
Peking University, a key national university of China, consists of six colleges and 29 departments. While placing stress on basic sciences, the university also pays special attention to the development of applied sciences. At present, Peking University has 45 research institutes, 52 research centers, two national engineering research centers, 42 key national disciplines, and five national key laboratories. Another six national key laboratories and four state special laboratories are under construction. The university effectively combines the research of important scientific issues with the training of personnel who have high levels of specialized knowledge and professional skills. Striving not only for simultaneous improvements in teaching and research work, but also for the promotion of interaction and mutual promotion among various subjects, the university has become a center for teaching and research. Its aim is to rank among the world's best universities by the beginning of the next century.
Fudan University Shanghai Medical College
Pharmanex Shanghai Research & Development Center
Pharmanex has built an R&D center on the campus of this university which is available to faculty and students. Established in 1994, Pharmanex Shanghai Research and Development Center is located in modern state-of-the-art laboratories on the campus of Shanghai Medical University. Pharmanex's first research and development facility in China, the center occupies 12,000 square feet of lab and office space and is staffed with 35 graduate scientists (Masters and Ph.D.s). The center is responsible for information and intelligence analysis, natural product chemistry, manufacturing process development, and analytical science in support of quality assurance. The center is directed by Professor De-chen Zhang, one of the most prominent medicinal natural product scientists in China.
Stanford University, California
In 1998, Nu Skin Enterprises opened the Nu Skin Center for Dermatological Research in collaboration with Stanford.
University of California at Los Angeles
Pharmanex Phytochemical Laboratory
In November of 1998, Pharmanex announced the seed funding of the Pharmanex Phytochemical Laboratory at the UCLA Center for Human Nutrition. This seed investment, along with expertise and guidance from Pharmanex chemists, led to the center's current funding by the National Institutes of Health. Built on strengths in chemistry, phytochemistry, and clinical and pharmacological studies on human nutrition, this partnership was the first of its kind for scientific research in the dietary supplement industry. The lab focuses on two areas: natural products research with quantitative finger printing of active components and nutrients and exploring the nutritional value of these supplements in relationship to modern health care maintenance. The laboratory is used to develop new understanding of the health benefits of dietary supplements based on the most advanced scientific findings available.
Pharmanex Beijing Association of Research & Development for Medico-Pharmaceutical Sciences
Pharmanex Beijing Association of Research & Development for Medico-Pharmaceutical Sciences was established in 1998, in cooperation with Beijing Association of Research & Development for Medico-Pharmaceutical Sciences (BARDMPS), an inter-University, inter-hospital organization staffed with about 20 high-level clinical professors. On a contract basis, BARDMPS is allowed to use 40 beds in a hospital for routine clinical use. These beds can be also used for Pharmanex clinical research projects. The center is responsible for clinical research and is directed by Dr. Josh Zhu and Professor Wang Baoen, a world-famous Gastroenterologist/Hepatologist, and Dean of the Second Clinical Faculty, Capital University of Medicine.
Pharmanex Beijing Clinical and Pharmacology Center
The Pharmanex Beijing Clinical and Pharmacology Center is actively engaged in research to determine the pharmacology-toxicology of natural products as well as the clinical benefits of those products. The center is run by Josh Zhu, M.D., Ph.D., Director of Clinical and Pharmacology Affairs for Pharmanex. Dr. Zhu leads a team of more than a dozen researchers with expertise in clinical medicine, pharmacology, biochemistry, physiology, toxicology, nutrition, and natural product chemistry. The center plays a major role in the Pharmanex research and product development process. As part of the Pharmanex 6S® Quality Process the Beijing Center is involved in all aspects of the selection, safety, and substantiation phases.
|
